CME ACTIVITY
Diabetic Microvascular Complications: Examining the Underlying Mechanisms and Understanding the Implications for Patient Care
Proceedings from a Symposium Held in Conjunction with the 12th International Congress of Endocrinology
Activity Date: December 2004
Activity Info: Volume 4, (10G)
 
 
 
--Corrections & Amplifications--
In the article by Solomon Tesfaye, MD, FRCP, entitled "Epidemiology and Etiology of Diabetic Peripheral Neuropathies", there was an error made in paragraphs one and two of page S1020. In reference to the dosing of ruboxistaurin in the Phase II study by Litchy, et. al., the correct dosing is every day (qd), and not 4 times per day.


Supported by an educational grant from
Eli Lilly and Company
 
 
     
 
Home | Contact Us | View Account | Need Help?